メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
プレス/メディア
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
二宮 匡史
助教
高度教養教育機構・学生支援機構・保健管理センター
h-index
1554
被引用数
23
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2006
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(83)
プレス/メディア
(3)
類似のプロファイル
(6)
フィンガープリント
Masashi Ninomiyaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
70%
Hepatitis B Virus
69%
Amino Acid
32%
Entecavir
29%
Chronic Hepatitis B
27%
Hepatitis C Virus
20%
Branched Chain Amino Acid
19%
Retrospective Study
18%
Hepatitis B Antigen
17%
Recurrent Disease
14%
Alanine Aminotransferase
14%
Tenofovir Alafenamide
13%
Virus DNA
12%
Lenvatinib
12%
Autoimmune Hepatitis
12%
Hepatitis C
12%
Primary Biliary Cirrhosis
12%
Serum Albumin
12%
Infection
12%
Virus Hepatitis
10%
Ursodeoxycholic Acid
10%
Liver Cirrhosis
10%
Acute Hepatitis
9%
Chronic Hepatitis C
9%
Virus Infection
8%
Leucine
8%
Hepatitis B
8%
Methionine
7%
Chronic Hepatitis
7%
Bezafibrate
7%
Acute Liver Failure
7%
Chemotherapy
7%
Tenofovir Disoproxil
7%
Tumor Invasion
6%
Hepatitis B Virus Genotype C
6%
Hepatitis B Virus Genotype B
6%
Monotherapy
6%
Survival Rate
6%
Lamivudine
6%
Tumor Necrosis Factor
6%
Insulin Dependent Diabetes Mellitus
6%
Immunoglobulin M Deficiency
6%
Immune Checkpoint Inhibitor
6%
Hepatotoxicity
6%
Very Low Density Lipoprotein
6%
Interstitial Pneumonia
6%
microRNA 29a
6%
Hepatitis E
6%
Tetraspanin
6%
Diabetic Nephropathy
6%
Immunology and Microbiology
Hepatitis B Virus
100%
Virus
39%
Hepatitis B
39%
Hepatitis C Virus
33%
Hepatitis C
27%
Amino Acid
19%
HBsAg
18%
Hepatitis B Antigen
18%
Anelloviridae
18%
Hepatitis Virus
16%
Viral Disease
16%
DNA Virus
13%
Dendritic Cell
12%
Tenofovir
12%
Alanine
12%
Torque Teno Virus 1
11%
T Cell
10%
Immunocompetent Cell
9%
Viral Replication
9%
Prevalence
9%
Maturation
8%
Immunopathogenesis
8%
Viral Protein
8%
Leucine
8%
Amino Acid Blood Level
8%
DNA Methylation
8%
CD14
7%
Blood Plasma
7%
Amino Acid Substitution
7%
Virus Quasispecies
7%
Hepatitis B(e) Antigen
7%
Drug Resistance
6%
Methylation
6%
Pegylated Interferon
6%
Membrane Antigen
6%
Virus Core
6%
Cytotoxic T-Cell
6%
Epithelial Mesenchymal Transition
6%
Tacrolimus
6%
Immunoglobulin M Deficiency
6%
Infancy
6%
Secretion (Process)
6%
CX3CL1
6%
Hepatitis Delta Virus
6%
Primary Biliary Cirrhosis
6%
Plasmapheresis
6%
Exosome
6%
Myeloid Dendritic Cell
6%
Pathogenesis of Autoimmune Disease
6%
Mycophenolate Mofetil
6%
Medicine and Dentistry
Hepatocellular Carcinoma
77%
Varices
19%
Lenvatinib
18%
Hepatitis B Virus
16%
Alanine Aminotransferase
14%
Transcatheter Arterial Chemoembolization
13%
Liver Transplantation
13%
Chronic Hepatitis C
13%
Retrospective Study
13%
Sclerotherapy
12%
Hepatitis C Virus
12%
Virus
12%
Skeletal Muscle
12%
Liver Tumor
10%
Bleeding
9%
Gene Mutation
9%
Portal Hypertension
9%
Hepatitis B
9%
Autoimmune Hepatitis
9%
Liver Cirrhosis
8%
Esophageal Varices
8%
Infection
8%
Entecavir
8%
Hepatocyte
7%
Primary Biliary Cirrhosis
7%
Fibrosis
7%
Hepatitis B Antigen
7%
Diseases
7%
Chronic Hepatitis
7%
Magnetic Resonance Imaging
7%
Sarcopenia
7%
Virus Infection
7%
Amino Acid
6%
Tenofovir Disoproxil
6%
Liver Fibrosis
6%
Liver Disease
6%
Virus Reactivation
6%
Computer Assisted Tomography
6%
Monotherapy
6%
Methionine
6%
Bezafibrate
6%
Sarcoidosis
6%
Nutritional Status
6%
Lung Metastasis
6%
Colecalciferol
6%
Elderly Patient
6%
Very Low Density Lipoprotein
6%
Response Evaluation Criteria in Solid Tumors
6%
Citrullinemia Type II
6%
Schistosomiasis Japonica
6%
